DNA RNA and Cells

01 Sep 2007 ATL1103 for Growth & Sight Disorders Project Update
31 Aug 2007 Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
30 Aug 2007 Lorus advances clinical development of GTI-2040 combined with Ara-c in acute myeloid leukemia
30 Aug 2007 Phase II Study of IMC-A12 for Advanced Prostate Cancer Commences Patient Enrollment
29 Aug 2007 Journal of American College of Cardiology Publishes Positive Findings on Generx Now in Phase 3 for Heart Disease
28 Aug 2007 Diamyd updates gene therapy program and outlines plans for Phase I clinical trial for treatment of cancer pain
28 Aug 2007 Geron Scientists and collaborators demonstrate human embryonic stem cell-derived cardiomyocytes improve heart function when transplanted after myocardial infarction
17 Aug 2007 Inovio Biomedical partner Tripep receives approval to initiate Phase I/II study of novel vaccine for hepatitis C virus
17 Aug 2007 Bioniche provides update on refractory bladder cancer trial
14 Aug 2007 Ophthotech raises $36 million; in-licenses two compounds for macular degeneration
14 Aug 2007 Pervasis Therapeutics Successfully Completes Enrollment for Vascugel(TM) Phase II Clinical Trials
11 Aug 2007 Proteo, Inc./Proteo Biotech AG - Minapharm/Rhein Minapharm Biogenetics SAE: Proteo Biotech, Germany and Minapharm, Egypt enter into development and license agreement for Elafin
10 Aug 2007 Tissera reports significant milestone achievement in its large animal diabetic model studies.
07 Aug 2007 Antisoma starts phase II trial of AS1411 in acute myeloid leukaemia
03 Aug 2007 Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
02 Aug 2007 OncoGenex Initiates Phase I Clinical Trial of OGX-427 in Cancer
01 Aug 2007 OncoGenex and Isis Report Encouraging Interim Phase II Data in Advanced Prostate Cancer, Affirm Phase III Clinical Trial Plans
31 Jul 2007 Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases
25 Jul 2007 Targeted Genetics' Inflammatory Arthritis Phase I/II Trial Placed on Clinical Hold
24 Jul 2007 Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Docetaxel trial
24 Jul 2007 Pluristem's PLX Cells Show Promise in Treating Limb Ischemia
21 Jul 2007 Expression Genetics, Inc. Announces Further Clinical Advancement of its Gene-Based IL-12 Therapy Co-administered with Standard Chemotherapy for Treatment of Ovarian Cancer
20 Jul 2007 EMEA Indicates that Genasense(R) Approval in Melanoma Will Require Confirmatory Clinical Trial
19 Jul 2007 FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
12 Jul 2007 Opko Health Initiates Phase 3 Trial of Bevasiranib for the Treatment of AMD

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up